Colorado life science companies brought in more than $12 billion in 2019

Colorado life sciences companies raised a combined $12.1 billion in 2019, thanks to the record-breaking acquisition of Boulder-based Array BioPharma by Pfizer (NYSE: PFE) for $11.4 billion. Without that massive acquisition, Colorado biotech still managed to raise $750 million through state and federal grants, financing rounds and other acquisitions, according to the Colorado Bioscience Association, which released the financial roundup on Dec. 17. Some of the highlights included Clo vis Oncology,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news